Historical record - last NADAC effective date: 1/1/2018
Product Information
ZYVOX 100 MG/5 ML SUSPENSION is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $8.7097 per ML under NDC 00009513601. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application on Apr 18, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the linezolid market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/5mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009513601
Classification
Brand
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Effective Date
1/1/2018
Active Ingredients
LINEZOLIDApproval Type
New Drug (NDA)
FDA Application
NDA021132FDA Approved
4/18/2000
TE Code
AB
On Market Since
4/18/2000
Pharmacological Classes
Price Statistics
The NADAC for ZYVOX 100 MG/5 ML SUSPENSION has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 128.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.7097 per ML |
|---|---|
| All-time high | $8.7097 (Jan 16, 2019) |
| All-time low | $3.8161 (Nov 28, 2013) |
| Median price | $6.6447 |
| Average price | $6.4417 |
| Largest weekly change | +12.0% (Jun 10, 2015) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+128.2%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the linezolid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZYVOX 100 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for ZYVOX 100 MG/5 ML SUSPENSION, manufactured by Pharmacia & Upjohn Company LLC, is $8.7097 per ML (NDC 00009513601), effective Jan 16, 2019.
How has the price of ZYVOX 100 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for ZYVOX 100 MG/5 ML SUSPENSION has risen 128.2%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZYVOX 100 MG/5 ML SUSPENSION?
Since Nov 28, 2013, the NADAC for ZYVOX 100 MG/5 ML SUSPENSION has ranged from a low of $3.8161 (Nov 28, 2013) to a high of $8.7097 (Jan 16, 2019), with a median of $6.6447 per ML.
Are there cheaper alternatives to ZYVOX 100 MG/5 ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of ZYVOX 100 MG/5 ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZYVOX 100 MG/5 ML SUSPENSION?
ZYVOX 100 MG/5 ML SUSPENSION (NDC 00009513601) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.